Equillium to present data at the 2020 american college of rheumatology meeting demonstrating cd6 modulation improves kidney and skin pathology in preclinical models of systemic lupus erythematosus

Studies  further validate  ongoing clinical  development of itolizumab for the treatment  of  systemic  lupus   erythematosus and lupus  nephritis
EQ Ratings Summary
EQ Quant Ranking